I'm similar, I don't think this hypothetical being discussed has...

I'm similar, I don't think this hypothetical being discussed has much chance of materialising.
I don't think the Board or any of the major holders see this as a sellable company, other than for an extraordinary amount.
The potential should be clear to all, including the major shareholders.
Only partnerships and licensing would realistically be on the table, in my opinion, a sale is not viable or sensible, to anyone, pre successful trial results, and even after successful trial results, it has minimal appeal as projected revenues by then would be more appealing than an instant gratification sale.
If the trial is successful and the anti-inflammatory aspect is locked in as proven, then the potential platform pathways would be nearly incalculable to consider a sale, unless, of course, it was extraordinary.